Trihexyphenidyl as a possible therapeutic option in clozapine-induced nocturnal enuresis

International Clinical Psychopharmacology

Volumn 11, Issue 1, 1996, Pages 61-63

  Poyurovsky, M ^a   Modai, I ^b,c   Weizman, A ^b,c  

^a Mental Health Center Tirat Carmel   (Israel)

^b GEHA MENTAL HEALTH CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

clozapine; enuresis; schizophrenia; trihexyphenidyl

Indexed keywords

CLOZAPINE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CASE REPORT; CHOLINERGIC SYSTEM; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MALE; NOCTURIA; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0029881851     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199603000-00010     Document Type: Article

References (15)

1. Bolden C, Cusak B and Richelson E (1992) Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. Journal of Pharmacology and Experimental Therapeutics, 260, 576-580.
2. Centorrino F, Baldessarini RJ, Kand JC et al. (1994) Clozapine and metabilities; concentrations in serum and clinical findings during treatment of chronically psychotic patients. Journal of Clinical Psychopharmacology, 14, 119-125.
3. Gerlach J and Peacock L (1994) Motor and mental side effects of clozapine. Journal of Clinical Psychiatry, 55 (Suppl B), 107-110.
4. Kane J, Hoingfeld G, Singer J and the Clozapine Collaborative Study Group (1988) Clozapine for the treatment-resistance schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
5. Kuchenhoff B (1993) Die wichtigsten Nebenwirkungen unter Clozapine (leponex) under ihre Behandlung. Psychiatrische Praxis, 20, 201-206.
6. Lieberman JA, Kane JM and Johus CA (1989) Clozapine: guidelines for clinical management. Journal of Clinical Psychiatry, 50, 329-338.
7. Lieberman JA, Safferman NZ, Pollack S et al. (1994) Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. American Journal of Psychiatry, 151, 1744-1752.
8. Meltzer HY (1994) An overview of the mechanism of action of Clozapine. Journal of Clinical Psychiatry, 55 (suppl), 168.
9. Merschel A, Oberie J and Rangoni F (1993) La Clozapine effect indesirables: etude dans les C.N.S. de la Region Alsace. La Pharmacie Hospitaliere Francaise, 106, 231-242.
10. Norgaard JP, Ritting S and Djurkuus JC (1989) Nocturnal enuresis: an approach to treatment based on pathogenesis. Journal of Pediatrics, 114, 705-714.
11. Poyurovsky M, Schneidman M, Mark M and Weizman A (1995) Verapamil treatment in clozapine-induced sleep-related enuresis: a case report. European Psychiatry 10, 413-415.
12. Rushton HG (1989) Nocturnal enuresis: epidemiology, evaluation, and currently available treatment options. Journal of Pediatrics, 114, 691-700.
13. Shriqui CL (1993) Treatment of clozapine-induced enuresis with desmopressin. Schizophrenia Research, 9, 251.
14. Staingard S (1994) Use of desmopressin to treat clozapine-induced nocturnal enuresis. Journal of Clinical Psychiatry, 55, 315-316.
15. Warner JP, Harvey CA and Barnes TRE (1994) Clozapine and urinary incontinence. International Clinical Psychopharmacology, 9, 207-209.